Our company

Pathelen Healthcare AG

Welcome to Pathelen Healthcare AG, a leading Swiss biotech company dedicated to researching and developing innovative therapies for over seven years. Our goal is to offer effective solutions for treating and curing various diseases, with a focus on combating bacteria and multi-resistant germs.

Pathelen Healthcare AG is committed to revolutionizing healthcare through non-pharmacological approaches. Our products are characterized by their safety and effectiveness because they rely on innovative technologies that do not require the use of cytotoxic or pharmacological agents. This is particularly important because such substances can hinder the formation of granulation tissue, which is crucial for the healing process.

An outstanding product that we have developed is Pathelen® Vulnerex. This innovative product is able to easily and effectively adsorb wound exudate, biofilm and pathogenic germs due to its physical mode of action. This unique technology offers pet owners a safe and effective solution for the wound care of their pets.

We are proud that our products are based on the latest scientific findings and are continually evolving. Our dedicated team of biotechnology and medical professionals are constantly working to optimize the effectiveness of our therapies and research new solutions.

Pathelen Healthcare AG sees itself as a partner for medical professionals and pet owners who are looking for safe and innovative treatment options. We attach great importance to transparency and understandable information about our products and their effects.

Thank you for your interest in Pathelen Healthcare AG. Together with you, we would like to contribute to a healthier future.